Drug & intervention

anakinra

RxCUI 72435

Clinical trials33
Recruiting0
Related conditions20
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…
Background context

Anakinra

Anakinra, sold under the brand name Kineret, is a biopharmaceutical medication used to treat rheumatoid arthritis, cryopyrin-associated periodic syndromes, familial Mediterranean fever, and Still's disease. It is a slightly modified recombinant version of the human interleukin 1 receptor antagonist protein. It is marketed by Swedish Orphan Biovitrum. Anakinra is administered by subcutaneous injection.

Read on Wikipedia ↗ Wikidata Q415411 ↗
Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

33 shown
The Effects of IL-1 Blockade on Inotrope Sensitivity in Patients With Heart Failure (AID-HEART)NCT06062966 · 2024-02-05
COMPLETED
Hyperinsulinemia in Prediabetes Mediated by Interleukin-1βNCT05854251 · 2023-06-15
COMPLETED
A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)NCT05814159 · 2022-08-24
ACTIVE_NOT_RECRUITING
Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With PrediabetesNCT05174507 · 2022-06-24
WITHDRAWN
Interleukin-1 Blockade in Acute Myocardial Infarction to Prevent Heart FailureNCT05177822 · 2022-05-24
ACTIVE_NOT_RECRUITING
Dupilumab_Metastatic NSCLCNCT05013450 · 2021-09-10
ACTIVE_NOT_RECRUITING
Anakinra as a Rescue Treatment for Allergic InflammationNCT04035109 · 2019-12-16
WITHDRAWN
A Study of CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate CancerNCT04227275 · 2019-11-22
TERMINATED
Anakinra for the Treatment of Chronically Inflamed White Matter Lesions in Multiple SclerosisNCT04025554 · 2019-10-25
COMPLETED
Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2NCT03797001 · 2019-01-04
COMPLETED
Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)NCT03182426 · 2017-08-15
COMPLETED
Interleukin-1 Blockade for the Treatment of Heart Failure in Patients With Advanced Chronic Kidney DiseaseNCT03062176 · 2017-04-03
WITHDRAWN
Role of Interleukin (IL)-1 in Postprandial Fatigue - The Chäschüechli 2 StudyNCT02916355 · 2016-08-01
COMPLETED
Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial HypertensionNCT03057028 · 2016-04-01
COMPLETED
Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic SyndromeNCT02672592 · 2016-01-01
COMPLETED
Anakinra, A Recombinant Human IL-1 Receptor Antagonist for Neuroinflammation in HIV-1 InfectionNCT02527460 · 2015-08-17
TERMINATED
Interleukin-1 Receptor Antagonist for the Treatment of Heart Failure in Patients With Left Ventricular Assist DevicesNCT02547766 · 2015-04-01
COMPLETED
Effects of IL-1 Beta on the HPA-axis in Obese PersonsNCT02227420 · 2014-10-01
COMPLETED
Interleukin-1 Blockade in HF With Preserved EFNCT02173548 · 2014-09-01
COMPLETED
Clinical Study to Evaluate the Efficacy of Anakinra in Patients With Rheumatoid Arthritis and DiabetesNCT02236481 · 2013-07-01
TERMINATED
Kineret in the Treatment of Rheumatoid ArthritisNCT02915094 · 2012-10-01
COMPLETED
Anti-IL-1 Treatment in Children Diabetic Keto-Acidosis (DKA) at Diagnosis of Type 1 DiabetesNCT01477476 · 2012-03-01
WITHDRAWN
Pilot Feasibility Study of the Safety and Efficacy of Anakinra in Heart Failure With Preserved Ejection FractionNCT01542502 · 2012-02-01
COMPLETED
Effects of Interleukin-1 Inhibition on Vascular and Left Ventricular Function in Rheumatoid Arthritis Patients With Coronary Artery DiseaseNCT01566201 · 2011-03-01
COMPLETED
Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Heart FailureNCT01300650 · 2011-02-01
COMPLETED
The Effect of Anakinra on Insulin SecretionNCT01285232 · 2011-01-01
UNKNOWN
Anakinra to Prevent Adverse Post-infarction Remodeling (2)NCT01175018 · 2010-07-01
COMPLETED
Anti-Interleukin-1 in Diabetes ActionNCT00711503 · 2009-01-01
COMPLETED
Anti-inflammatory Therapy With Anakinra in Newly Diagnosed Type 1 DiabetesNCT00645840 · 2008-03-01
COMPLETED
Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized StudyNCT01033656 · 2005-12-01
COMPLETED
The SPECTRA StudyNCT00537667 · 2001-08-01
TERMINATED
Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid ArthritisNCT00037700 · 2001-05-01
COMPLETED
Juvenile Rheumatoid ArthritisNCT00037648 · 2000-07-01
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.